About Us

ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast cancer and melanoma. Founded by an experienced group of scientists and entrepreneurs with successful track record, we are committed to diligently search and deliver best-in-class and first-in-class medicines for the needed patients worldwide.

News

ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in th...

Read more

Meet ABM Therapeutics at AACR Annual Meeting 2020...

Read more

ABM Therapeutics Appointed Dr. Charles Zhao as Chief Medical Officer for Clinical Trials...

Read more

© 2019 Wall Calvin technology.Powered by Webfoss.

Legal claim|Privacy policy